Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) With Ultravist 370 INJ.(Iopromide 768.86mg) in Abdominal CT

• Status: Completed
• Trial end date: 2013-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of NEOVIST 370 INJ.(Iopromide 768.86mg) with Ultravist 370 INJ.(Iopromide 768.86mg) in abdominal CT

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital

Criteria

Inclusion Criteria:

• Aged 20 to 75 years old.

• Subjects who need CT scan

• Subjects who are willing to participate in the study and to write the informed consent form.

Exclusion Criteria:

• Subjects with severe hepatopathy whose AST or ALT ≥ 1,000 IU/L, Subjects with liver cirrhosis whose AST or ALT ≥ UNL(upper normal limit) X 3

• Severe disorder of thyroid gland

• homocystinuria

• pregnant or breastfeeding female subjects, or female subjects with childbearing potential who are not willing to use proper contraception methods

• Participation in another clinical trial within 30days of enrollment into this study.